Interim analysis of ABM-1310, a blood-brain barrier-penetrant BRAF inhibitor, in patients with BRAF V600-mutated solid tumors.
EMBED <iframe src="https://archive.org/embed/youtube-0NpwitfBXTI" width="560" height="384" frameborder="0" webkitallowfullscreen="true" mozallowfullscreen="true ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results